224 related articles for article (PubMed ID: 25918673)
1. Novel (89)Zr cell labeling approach for PET-based cell trafficking studies.
Bansal A; Pandey MK; Demirhan YE; Nesbitt JJ; Crespo-Diaz RJ; Terzic A; Behfar A; DeGrado TR
EJNMMI Res; 2015; 5():19. PubMed ID: 25918673
[TBL] [Abstract][Full Text] [Related]
2.
Kahts M; Guo H; Kommidi H; Yang Y; Sayman HB; Summers B; Ting R; Zeevaart JR; Sathekge M; Aras O
EJNMMI Radiopharm Chem; 2023 Nov; 8(1):36. PubMed ID: 37930454
[TBL] [Abstract][Full Text] [Related]
3. Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling.
Bansal A; DeGrado TR; Pandey MK
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37955388
[TBL] [Abstract][Full Text] [Related]
4. [
Bansal A; Pandey MK; Yamada S; Goyal R; Schmit NR; Jeon R; Nesbitt JJ; Witt TA; Singh RD; Gunderson TM; Boroumand S; Li M; Crespo-Diaz RJ; Hillestad ML; Terzic A; Behfar A; DeGrado TR
Nucl Med Biol; 2020; 90-91():23-30. PubMed ID: 32957056
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of 89Zr-oxine-labeled human bone marrow-derived mesenchymal stem cells by micro-PET/computed tomography imaging in Sprague-Dawley rats.
Wang S; Wang Y; Xu B; Qin T; Lv Y; Yan H; Shao Y; Fang Y; Zheng S; Qiu Y
Nucl Med Commun; 2022 Jul; 43(7):834-846. PubMed ID: 35438673
[TBL] [Abstract][Full Text] [Related]
6. (89)Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies.
Sato N; Wu H; Asiedu KO; Szajek LP; Griffiths GL; Choyke PL
Radiology; 2015 May; 275(2):490-500. PubMed ID: 25706654
[TBL] [Abstract][Full Text] [Related]
7. Site-specifically labeled
Kristensen LK; Christensen C; Jensen MM; Agnew BJ; Schjöth-Frydendahl C; Kjaer A; Nielsen CH
Theranostics; 2019; 9(15):4409-4420. PubMed ID: 31285769
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of different
Bansal A; Sharma S; Klasen B; Rösch F; Pandey MK
Sci Rep; 2022 Sep; 12(1):15646. PubMed ID: 36123386
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
[TBL] [Abstract][Full Text] [Related]
10. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
Al-Saden N; Lam K; Chan C; Reilly RM
Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
[TBL] [Abstract][Full Text] [Related]
11. Detection limit of
Lechermann LM; Manavaki R; Attili B; Lau D; Jarvis LB; Fryer TD; Bird N; Aloj L; Patel N; Basu B; Cleveland M; Aigbirhio FI; Jones JL; Gallagher FA
EJNMMI Res; 2020 Jul; 10(1):82. PubMed ID: 32666311
[TBL] [Abstract][Full Text] [Related]
12. Tracking of NK Cells by Positron Emission Tomography Using
Sato N; Szajek LP; Choyke PL
Methods Mol Biol; 2022; 2463():153-161. PubMed ID: 35344173
[TBL] [Abstract][Full Text] [Related]
13. PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with
Weist MR; Starr R; Aguilar B; Chea J; Miles JK; Poku E; Gerdts E; Yang X; Priceman SJ; Forman SJ; Colcher D; Brown CE; Shively JE
J Nucl Med; 2018 Oct; 59(10):1531-1537. PubMed ID: 29728514
[TBL] [Abstract][Full Text] [Related]
14. Imaging of cell-based therapy using
Kurebayashi Y; Choyke PL; Sato N
Nanotheranostics; 2021; 5(1):27-35. PubMed ID: 33391973
[TBL] [Abstract][Full Text] [Related]
15. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.
Pérez-Medina C; Tang J; Abdel-Atti D; Hogstad B; Merad M; Fisher EA; Fayad ZA; Lewis JS; Mulder WJ; Reiner T
J Nucl Med; 2015 Aug; 56(8):1272-7. PubMed ID: 26112022
[TBL] [Abstract][Full Text] [Related]
16. In Vivo PET Imaging of Monocytes Labeled with [
Krekorian M; Cortenbach KRG; Boswinkel M; Kip A; Franssen GM; Veltien A; Scheenen TWJ; Raavé R; van Riessen NK; Srinivas M; de Vries IJM; Figdor CG; Aarntzen EHJG; Heskamp S
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680219
[TBL] [Abstract][Full Text] [Related]
17. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
[TBL] [Abstract][Full Text] [Related]
18. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
[TBL] [Abstract][Full Text] [Related]
19. A new solid target design for the production of
Pandey MK; Bansal A; Ellinghuysen JR; Vail DJ; Berg HM; DeGrado TR
Am J Nucl Med Mol Imaging; 2022; 12(1):15-24. PubMed ID: 35295887
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET.
Miller L; Winter G; Baur B; Witulla B; Solbach C; Reske S; Lindén M
Nanoscale; 2014 May; 6(9):4928-35. PubMed ID: 24675844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
